USD10
HURA Shares
About TuHURA BiosciencesTuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
USD10
HURA Shares
About TuHURA BiosciencesTuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$143.29M
OPEN PRICE
$2.17
LOW (1Y)
$0.41
HIGH (1Y)
$3.90
LOW (24H)
$2.17
HIGH (24H)
$2.28
VOLUME (24H)
$162.5K
66.94%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.17 | |
1 Day | $2.22 | |
1 Week | $2.44 | |
1 Month | $2.24 | |
1 Year | $2.55 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.